{"resourceId":"powerfulmedical-corpuls-queen-of-hearts-20261001","versions":[{"version":"external-d37cc357cd81f1553c7b3e1c6d59379cee1cf0519dc1898699ea3d1319655121","resource":{"id":"powerfulmedical-corpuls-queen-of-hearts-20261001","title":"Powerful Medical and corpuls partner to embed Queen of Hearts AI ECG in prehospital corpuls devices (EU/UK/CH start)","organization":"Powerful Medical / corpuls","sector":"Prehospital EMS / cardiac emergency care technology","geography":"European Union, Switzerland, United Kingdom (stated launch); vendor claims global corpuls footprint in 70+ countries","publishedAt":"2026-10-01","publicationDate":"2026-10-01","eventDate":"2026-10-01","sourceName":"Powerful Medical","sourceLabel":"Vendor partnership announcement for Queen of Hearts AI ECG on corpuls prehospital platform","sourceUrl":"https://www.powerfulmedical.com/blog/powerful-medical-and-corpuls-partner-to-bring-queen-of-hearts-ai-powered-heart-attack-detection-to-prehospital-care/","evidenceClass":"vendor-claim","outcomeClass":"emerging","topics":["infrastructure","knowledge-work","operating-model","data-security"],"finding":"On October 1, 2026, Powerful Medical announced a partnership with corpuls to integrate the Queen of Hearts AI ECG model into corpuls monitor/defibrillator and telemedicine systems used by emergency professionals in over 70 countries, starting in the EU, Switzerland, and the United Kingdom. A 12-lead ECG on a corpuls3 would return STEMI and STEMI-equivalent (OMI) AI interpretation within seconds via corpuls.mission LIVE, with hospital PMcardio displaying the same finding for cath-lab readiness. The vendor states ~40% of occlusions lack classic ST-elevation; claims Queen of Hearts was trained on >2.5M angiographically labeled ECGs, doubles sensitivity vs STEMI criteria, reduces false cath-lab activations from 42% to 8%, and cites a Belgian prospective implementation cutting time-to-treatment by 48 minutes (STEMI-equivalent ~six hours sooner). FDA De Novo approval is highlighted on the site banner.","sledRelevance":"Prehospital EMS cardiac AI-ECG is squarely in emergency-services; U.S. SLED transferability limited until local device/regulatory paths and independent outcomes are shown.","evidence":"Vendor partnership press page with cited performance statistics and prior implementation claims; not an independent trial report.","architectureImplications":"On-device/telemedicine AI ECG labels shared ambulance-to-hospital without separate hardware; depends on corpuls.mission LIVE connectivity.","governanceImplications":"Clinical accept/reject of AI-OMI labels and cath-lab activation authority remain human medical-direction problems; partnership does not define liability allocation.","securityPrivacyImplications":"Live ECG/PHI transmission to hospital platforms requires strong telemedicine security and data-processing agreements.","caveats":"Vendor claims; EU/UK/CH start; Belgian/retrospective citations not re-audited here; FDA banner is not the same as this partnership’s geographic launch evidence.","streamIds":["emergency-services"],"roles":{"sales":"Frame the Oct 1 Powerful Medical–corpuls partnership as a prehospital OMI/STEMI-equivalent AI-ECG integration path for agencies already on corpuls hardware in EU/UK/CH—not a U.S. blanket EMS claim. Discovery should separate FDA De Novo banner claims from the partnership’s stated geographic start and ask for angiographic outcome evidence packages. Bounded engagement: map ECG→AI→mission LIVE→hospital PMcardio workflow against local cath-lab activation protocols. Unsupported claims include guaranteed 48-minute gains, U.S. field outcomes from this release, or zero false activations.","engineering":"Architecturally, Queen of Hearts sits on corpuls3 12-lead capture with corpuls.mission LIVE returning AI STEMI/OMI labels in seconds and optional hospital PMcardio mirroring. Prerequisites: corpuls fleet, LIVE connectivity, hospital receiving path, and clinical governance for OMI vs STEMI criteria. Constraints: vendor-stated performance; EU/UK/CH launch first. Proof of value: false cath-lab activation rate, missed OMI rate, and contact-to-balloon times under dual human+AI review—not marketing sensitivity claims alone.","delivery":"Sequence device firmware/LIVE enablement, paramedic training on AI-ECG display, hospital cath-lab notification SOP, and outcome feedback to crews. Ownership: EMS medical director for clinical accept; corpuls/Powerful Medical for integration. Risks: treating vendor Belgian/retrospective claims as local proof, skipping false-positive governance, and deploying without offline/degraded-mode procedures."},"roleDetails":{"sales":{"customerProblem":"Prehospital teams miss OMI without classic STEMI and over-activate cath labs on false STEMI criteria.","stakeholders":["EMS medical directors","Paramedics","Receiving cardiology/cath lab","Device vendors"],"discoveryQuestions":["Is corpuls already in the fleet?","What is today’s false cath-lab activation rate?","Who can override AI-ECG labels?","Which geographies/regulatory clearances apply?"],"valueHypothesis":"Embedded AI-ECG can reduce missed OMI and false activations if prospectively measured under medical-director governance.","potentialEngagement":"Clinical workflow workshop aligning AI-ECG alerts to local STEMI/OMI activation protocols.","unsupportedClaims":["Guaranteed 48-minute improvement from this release","U.S. deployment readiness","Zero missed OMI"]},"engineering":{"fit":"AI ECG interpretation embedded in prehospital monitor/defib and telemedicine path.","architectureIntegration":"corpuls3 ECG → Queen of Hearts via mission LIVE → on-device result + hospital PMcardio.","prerequisites":["corpuls devices","LIVE network","Hospital PMcardio or equivalent","Clinical protocol update"],"constraints":["EU/UK/CH start","Vendor-claimed metrics","Connectivity dependent"],"security":"ECG/PHI transmission via LIVE/telemedicine requires HIPAA/GDPR-equivalent controls and vendor BAAs.","proofOfValue":["False activation rate","Missed OMI audits","Contact-to-balloon under AI+human"]},"delivery":{"work":"Enable LIVE AI path, train crews, align hospital notification, log outcomes back to EMS.","dependencies":["corpuls firmware/LIVE","Hospital cardiology IT","Medical direction","Connectivity"],"ownership":"EMS medical director owns clinical use policy; vendors own model/device integration.","skillsAdoption":"Train paramedics to treat AI labels as decision support with documented override.","governanceCheckpoints":["Medical-director approval","False-activation review board","Degraded-mode drill"],"acceptanceCriteria":["Override documented","Outcome feedback loop live","Activation KPI baseline set"],"risks":["Vendor-claim overfit","Connectivity failure","Alert fatigue"]}},"retrievedAt":"2026-10-03T22:01:34-05:00","enrichedAt":"2026-10-03T22:01:34-05:00","enrichmentBasis":"retrieved source","accessibilityWorkforceImplications":"Aims to put AI interpretation in paramedics’ existing device workflow rather than a separate app—reduces UI burden if training covers overrides.","procurementImplications":"Hardware-locked to corpuls ecosystem; agencies not on corpuls face switching costs; demand independent clinical evidence packs in RFP.","operatingModelImplications":"Shifts some ECG triage judgment earlier in the EMS chain with hospital mirroring—requires joint EMS–cardiology protocols.","sourceVerification":{"responseId":"curl-powerfulmedical-qoh-corpuls-20261003T220134","openedUrl":"https://www.powerfulmedical.com/blog/powerful-medical-and-corpuls-partner-to-bring-queen-of-hearts-ai-powered-heart-attack-detection-to-prehospital-care/","referenceExcerpt":"Around 40 percent of occlusions do not show the classic ST-elevation pattern","promptVersion":"sled-research-v4.0","model":null,"basis":"agent-reported inspection"}}}]}